📌 What’s happening?
Provision 133700, tucked into the current North Carolina House budget proposal, would eliminate Medicaid coverage for evidence-based anti-obesity medications, including widely used GLP-1 therapies.
📉 What this means:
This isn’t about cosmetic weight loss— it’s about treating obesity as a serious medical disease. These medications help manage chronic conditions like heart disease, diabetes, and kidney failure, and they're proven to reduce heart attacks, strokes, and long-term healthcare costs.
🧠 Why it matters:
Over 1 in 3 North Carolinians live with obesity.
These medications are standard of care— not luxury drugs.
Cutting coverage will hit low-income residents the hardest, worsening health disparities.
Studies show that GLP-1 therapies can lead to a >40% reduction in major cardiac events and 7% lower medical costs by year two (AON Study, 2025).
🔗 Link to Article:
https://lnkd.in/ebSRBV7C
🏛️ CALL TO ACTION
We urge the North Carolina General Assembly to strike Provision 133700 from the budget before this week’s vote.
💬 NC Residents: Email or call your House representative and tell them to protect Medicaid access to anti-obesity care.
📄 Find your NC House Member here:
👉🏻 https://lnkd.in/ey3gKsKY
📣 MEDIA, PLEASE SHARE:
Help inform the public before it’s too late. This issue affects real families, healthcare workers, and our state’s future health costs.
📢 Contact:
North Carolina Obesity Society
📧 info@ncobesitysociety.org
🌐 ncobesitysociety.org
hashtag#NCMedicaid hashtag#GLP1 hashtag#NCHealth hashtag#ObesityCare hashtag#ProtectMedicaid hashtag#NCGA hashtag#NorthCarolina hashtag#PublicHealth
GLP-1s can help employers lower medical costs in 2 years, new study finds
cnbc.com
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.
In this session, Jeff Young MS, CSCS, EdD(c) will walk you through bridging the gap between medicine and fitness!